Viral Hepatitis
Copyright ©The Author(s) 2002.
World J Gastroenterol. Dec 15, 2002; 8(6): 1077-1080
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1077
Table 1 Statistical analysis of the relevance of expression of sTRAIL and clinical staging of hepatitis B
nsTRAIL( × 10-9μg/mL)
HBV carriers8876.88 ± 369.59
Chronic hepatitis301494.97 ± 533.24
Mild chronic hepatitis91138.90 ± 424.90
Moderate chronic hepatitis121558.65 ± 489.87a
Severe chronic hepatitis91812.78 ± 499.99b
HBV infectious related cirrhosis111375.00 ± 526.08c
HBV related infectious liver cancer31561.00 ± 449.56d
Table 2 Analysis of corelation between the expression of sTRAIL and clinical indices of hepatitis B
sTRAILClinical indicesCorrelativity coeffficient
HBV carrier876.88 ± 369.59ALT28.38 ± 5.09
Tbil17.73 ± 3.34
ALB39.5 ± 1.20
Chronic hepatitis1494.97 ± 533.24ALT173.61 ± 135.32r = 0.496(P < 0.01)
Tbil66.79 ± 61.73
ALB32.95 ± 5.86r = -0.392(P < 0.05)
HBV infectious related cirrhosis1375.00 ± 526.08ALT150.36 ± 132.72
Tbil82.83 ± 118.00
ALB34.01 ± 5.79
HBV infectious related liver cancer1561 ± 449.56ALT85.67 ± 48.76
Tbil58.81 ± 24.43
ALB36.63 ± 10.07
Table 3 Analysis of correlation between the expression of HBsAg and that of sTRAIL
Group divided by S/NnExpression of HBsAg(S/N)Expression of sTRAIL in peripheral blood ( × 10-9μg/mL)
< 2.1(-)20.5 ± 0.71852.50 ± 123.74
> 2.1 and < 10(+)0
> 10 and < 30(++)0
> 30 and < 50(+++)443.25 ± 3.781693.75 ± 547.76
> 50(++++)4661.48 ± 5.191330.30 ± 537.80
Table 4 Analysis of the correlation between Expression of HBeAg and that of sTRAIL
Group divided by S/NcasesThe expression of HBeAg(S/N)Expression of sTRAIL in peripheral blood ( × 10-9μg/mL)
< 2.1(-)140.86 ± 0.511166.81 ± 448.84
> 2.1 and < 10(+)95.47 ± 2.881088.33 ± 528.27a
> 10 and < 30(++)1920.79 ± 5.391590.26 ± 474.81ab
> 30 and < 50(+++)436.06 ± 4.821655.00 ± 534.48a
> 50(++++)654.69 ± 4.491730.83 ± 652.64bc